Literature DB >> 17889038

Homozygosity at variant MLH1 can lead to secondary mutation in NF1, neurofibromatosis type I and early onset leukemia.

Hani Alotaibi1, Marie D Ricciardone, Mehmet Ozturk.   

Abstract

Heterozygous germ-line variants of DNA mismatch repair (MMR) genes predispose individuals to hereditary non-polyposis colorectal cancer. Several independent reports have shown that individuals constitutionally homozygous for MMR allelic variants develop early onset hematological malignancies often associated to features of neurofibromatosis type 1 (NF1) syndrome. The genetic mechanism of NF1 associated to MMR gene deficiency is not fully known. We report here that a child with this form of NF1 displays a heterozygous NF1 gene mutation (c.3721C>T), in addition to a homozygous MLH1 gene mutation (c.676C>T) leading to a truncated MLH1 protein (p.R226X). The parents did not display NF1 features nor the NF1 mutation. This new NF1 gene mutation is recurrent and predicts a truncated neurofibromin (p.R1241X) lacking its GTPase activating function, as well as all C-terminally located functional domains. Our findings suggest that NF1 disease observed in individuals homozygous for deleterious MMR variants may be due to a concomitant NF1 gene mutation. The presence of both homozygous MLH1 and heterozygous NF1 mutation in the child studied here also provides a mechanistic explanation for early onset malignancies that are observed in affected individuals. It also provides a model for cooperation between genetic alterations in human carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889038     DOI: 10.1016/j.mrfmmm.2007.08.003

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  10 in total

1.  Constitutional mismatch repair-deficiency syndrome.

Authors:  Katharina Wimmer; Christian P Kratz
Journal:  Haematologica       Date:  2010-05       Impact factor: 9.941

2.  Predictive genetic testing in children: constitutional mismatch repair deficiency cancer predisposing syndrome.

Authors:  Zandrè Bruwer; Ursula Algar; Alvera Vorster; Karen Fieggen; Alan Davidson; Paul Goldberg; Helen Wainwright; Rajkumar Ramesar
Journal:  J Genet Couns       Date:  2013-10-15       Impact factor: 2.537

Review 3.  Genetic intersection of male infertility and cancer.

Authors:  Liina Nagirnaja; Kenneth I Aston; Donald F Conrad
Journal:  Fertil Steril       Date:  2018-01       Impact factor: 7.329

4.  Agenesis of the corpus callosum and gray matter heterotopia in three patients with constitutional mismatch repair deficiency syndrome.

Authors:  Annette F Baas; Michael Gabbett; Milan Rimac; Minttu Kansikas; Martine Raphael; Rutger Aj Nievelstein; Wayne Nicholls; Johan Offerhaus; Danielle Bodmer; Annekatrin Wernstedt; Birgit Krabichler; Ulrich Strasser; Minna Nyström; Johannes Zschocke; Stephen P Robertson; Mieke M van Haelst; Katharina Wimmer
Journal:  Eur J Hum Genet       Date:  2012-06-13       Impact factor: 4.246

5.  Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patients.

Authors:  Sabrina Titze; Hartmut Peters; Sandra Währisch; Thomas Harder; Katrin Guse; Annegret Buske; Sigrid Tinschert; Anja Harder
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

6.  RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A.

Authors:  Terje Ahlquist; Irene Bottillo; Stine A Danielsen; Gunn I Meling; Torleiv O Rognum; Guro E Lind; Bruno Dallapiccola; Ragnhild A Lothe
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

7.  Three independent mutations in the TSC2 gene in a family with tuberous sclerosis.

Authors:  Cédric Le Caignec; David J Kwiatkowski; Sébastien Küry; Jean-Benoit Hardouin; Judith Melki; Albert David
Journal:  Eur J Hum Genet       Date:  2009-03-04       Impact factor: 4.246

8.  Unique mutational profile associated with a loss of TDG expression in the rectal cancer of a patient with a constitutional PMS2 deficiency.

Authors:  P Vasovcak; A Krepelova; M Menigatti; A Puchmajerova; P Skapa; A Augustinakova; G Amann; A Wernstedt; J Jiricny; G Marra; K Wimmer
Journal:  DNA Repair (Amst)       Date:  2012-05-17

Review 9.  Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants.

Authors:  Hildegard Kehrer-Sawatzki; David N Cooper
Journal:  Hum Genet       Date:  2021-12-20       Impact factor: 4.132

10.  Clinical presentation and genetic analyses of neurofibromatosis type 1 in independent patients with monoallelic double de novo closely spaced mutations in the NF1 gene.

Authors:  Alessandro Stella; Patrizia Lastella; Luigi Viggiano; Rosanna Bagnulo; Nicoletta Resta
Journal:  Hum Mutat       Date:  2022-06-28       Impact factor: 4.700

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.